ReviewInternational archives of otorhinolaryngology2026
Public Hearing Aid Policies in Brazil: Operational Gaps, Replacement Costs, and Data Governance in the Unified Health System (SUS).
Review in International archives of otorhinolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The Brazilian Unified Health System (SUS, from the Portuguese Sistema Único de Saúde) provides free hearing aids (HAs), including otological evaluation, audiological therapy, audiological exams, and ear molds through authorized centers. In addition to the complexity and high investment costs, there is no centralized government agency to manage these resources, so each authorized center works on its own. On the other hand, HAs providers are independent distributors or subsidiaries driven by profit and key-performance indicators in their best interest. Objectives: To analyze the operational efficiency of SUS in the provision of HAs and explore potential improvements through digital data governance and optimization of replacement rates through simulations. Data Synthesis: We accessed national data from 2008 to 2024 through the Ministry of Development, Industry and Foreign Trade (COMEX/MDIC) and SUS's Department of Informatics (DATASUS). We integrated these sources with operational data from Reouvir, a leading SUS-accredited center, to model cost scenarios and identify management inefficiencies. Cases from SUS accounted for an average of 49.9% of Brazil's HA imports (3.48 million units, US$437 million). However, high replacement rates-some exceeding 70%-suggest inefficiencies. Simulations indicate that reducing replacement rates by 5 to 20% could yield annual savings of US$1.23 to 5.15 million or enable an increase of 9,780 to 41,026 new fittings per year, respectively. Conclusion: Despite its robust public policy, SUS lacks performance monitoring to enable suppliers to shape market dynamics. Improved digital governance could enhance cost-efficiency and access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.